Saint Kitts and Nevis

Reimbursed Care Access

Saint Kitts and Nevis is a party to the UN psychotropic and narcotics conventions and applies domestic controlled‑drugs legislation that treats classic psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑series, etc.) as controlled/illegal outside tightly regulated contexts. Ketamine is available as a licensed anesthetic (WHO essential medicine) and therefore accessible within the formal health system; licensed psychedelic therapeutics (e.g., esketamine/Spravato) have no clear public evidence of local market authorization or public reimbursement as of February 20, 2026. Clinical/research access is the only realistic route for most classic psychedelics. [https://treaties.un.org/Pages/ViewDetails.aspx?src=IND&mtdsg_no=VI-15&chapter=6|UN Treaty Depository — Convention on Psychotropic Substances] [https://kn.vlex.com/vid/the-government-of-the-793480017|vLex — Drugs (Prevention of Misuse) Act references].